HCV-IN-4, a potent and orally active inhibitor of HCV NS5A, demonstrates significant efficacy against genotypes GT1a, GT2b, GT3a, and the GT1a mutations Y93H and L31V. Its half-maximal effective concentrations (EC90s) are 3 pM, 0.3 nM, 0.01 nM, 0.5 nM, and 0.02 nM, respectively[1].
Molecular Weight:
956.07
CAS Number:
[2058080-25-2]
Formula:
C52H58FN9O8
Target:
HCV Protease
TP1468
* VAT and and shipping costs not included. Errors and price changes excepted
